Immunotherapeutics for biodefense

Details Immunotherapeutics for biodefense Immunotherapeutics for biodefense

C - Chemistry, Metallurgy

07

K

C07K 16/12 (2006.01) C07K 16/08 (2006.01) C07K 16/10 (2006.01) C12N 15/10 (2006.01) G01N 33/569 (2006.01)

Patent

CA 2475735

Human neutralizing antibodies (full-length or functional fragments) are useful as anti-toxins or anti-infectives with respect to infective agents such as, for example, anthrax, botulinum, smallpox, Venezuelan equine encephalomyelitis virus (VEEV), West Nile virus (WNV) and the like.

L'invention concerne des anticorps humains de neutralisation (longueur totale ou fragments fonctionnels) utiles comme antitoxines ou agent anti-infectieux contre des agents infectieux tels que, par exemple, l'anthrax, la toxine botulinique, la variole, le virus encéphalitique du cheval de Venezuela (VEEV), le virus du Nil occidental (WNV) et analogue.

Affiliated with

Also associated with

Rating

Immunotherapeutics for biodefense does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Immunotherapeutics for biodefense, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutics for biodefense will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1930910